Key result
Resveratrol reduces cytotoxicity, NO content, and apoptosis in human endothelial cells exposed to malondialdehyde.
Why the study?
Vascular injury occurs during diabetic changes following the production of several byproducts, prompting investigation into alternative therapies such as resveratrol.
Does resveratrol reduce malondialdehyde-induced cytotoxicity and apoptosis in human endothelial cells?
Does resveratrol reduce malondialdehyde-induced cytotoxicity and apoptosis in human endothelial cells?
p-value: p=< 0.05
Resveratrol demonstrates protective effects against malondialdehyde-induced vascular injury in human endothelial cells by reducing cytotoxicity and apoptosis.
Introduction: According to the statistics, vascular injury occurs during the onset of diabetic changes after the production of several byproducts. Many authorities have focused to find an alternative therapy for diabetic patients. In this study, we investigated the therapeutic effects of natural polyphenol like resveratrol on human endothelial cells exposed to malondialdehyde for 48 hours. Methods: Human Umbilical Vein Endothelial Cells were randomly classified into four groups;control, malondialdehyde (2.5 mM), resveratrol (100 μM), and cells received the combined regime for 48 hours. Cell viability was determined by 3-(4, 5-dimethyl thiazol-2-yl) 2, 5-diphenyl-tetrazoliumbromide (MTT) assay. Griess reaction was performed to measure the content of Nitric oxide (NO).Apoptosis was studied by using real-time polymerase chain reaction (RT-PCR) and western blotting assays. Levels of receptor tyrosine kinases like VEGFR-1, -2, Tie-1, and -2 were analyzed by enzyme-linked immunosorbent assay(ELISA). The affinity of resveratrol and malondialdehyde to serum albumin was measured by Surface Plasmon Resonance Assay. Any changes in chromatin remodeling were detected by PCR array analysis. Results: Resveratrol reduced cytotoxicity and NO content inside cells induced by malondialdehyde(MDA) (P < 0.05). Endothelial cell apoptosis was decreased by the reduction of pro-apoptotic factor Bax and increase of Bcl-2 following the incubation with resveratrol (P < 0.05). MDA-induced receptor tyrosine kinases increase was inhibited by resveratrol and reached near-to-normal levels (P < 0.05).Surface Plasmon Resonance revealed a higher affinity of resveratrol to albumin compared to the malondialdehyde-albumin complex. Polymerase chain reaction (PCR) array revealed the potency of resveratrol in chromatin remodeling following the treatment with malondialdehyde (P < 0.05). Conclusion: Based on our findings, resveratrol has the potential to decrease diabetic vascular injury induced by lipid byproducts such as MDA.
No takes yet. Share an insight, caveat, or question.
Hassanpour et al. (2021) studied diabetic vascular injury. resveratrol vs. control, malondialdehyde (2.5 mM) was evaluated on cytotoxicity and NO content (p=< 0.05). Resveratrol reduced cytotoxicity, NO content, and apoptosis in human endothelial cells exposed to malondialdehyde (P < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: